SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-23-007405
Filing Date
2023-03-21
Accepted
2023-03-21 16:39:46
Documents
1
Period of Report
2023-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3816
  Complete submission text file 0001437749-23-007405.txt   5490
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Issuer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 1325 AVENUE OF AMERICAS, 28TH FLR. NEW YORK NY 10019
Business Address
Lindborg Stacy (Reporting) CIK: 0001813667 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15911 | Film No.: 23750151